122 related articles for article (PubMed ID: 24217388)
1. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL.
Nguyen HT; Geens M; Mertzanidou A; Jacobs K; Heirman C; Breckpot K; Spits C
Mol Hum Reprod; 2014 Feb; 20(2):168-77. PubMed ID: 24217388
[TBL] [Abstract][Full Text] [Related]
2. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures.
Avery S; Hirst AJ; Baker D; Lim CY; Alagaratnam S; Skotheim RI; Lothe RA; Pera MF; Colman A; Robson P; Andrews PW; Knowles BB
Stem Cell Reports; 2013; 1(5):379-86. PubMed ID: 24286026
[TBL] [Abstract][Full Text] [Related]
3. Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment.
Markouli C; Couvreu De Deckersberg E; Regin M; Nguyen HT; Zambelli F; Keller A; Dziedzicka D; De Kock J; Tilleman L; Van Nieuwerburgh F; Franceschini L; Sermon K; Geens M; Spits C
Stem Cell Reports; 2019 Jul; 13(1):163-176. PubMed ID: 31178415
[TBL] [Abstract][Full Text] [Related]
4. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal.
Bai H; Chen K; Gao YX; Arzigian M; Xie YL; Malcosky C; Yang YG; Wu WS; Wang ZZ
Stem Cell Res; 2012 Jan; 8(1):26-37. PubMed ID: 22099018
[TBL] [Abstract][Full Text] [Related]
6. TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells.
Kim YJ; Go YH; Jeong HC; Kwon EJ; Kim SM; Cheong HS; Kim W; Shin HD; Lee H; Cha HJ
Exp Mol Med; 2023 Jan; 55(1):32-42. PubMed ID: 36596852
[TBL] [Abstract][Full Text] [Related]
7. A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1.
Türkmen S; Riehn M; Klopocki E; Molkentin M; Reinhardt R; Burmeister T
Genes Chromosomes Cancer; 2011 Jun; 50(6):389-96. PubMed ID: 21412927
[TBL] [Abstract][Full Text] [Related]
8. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.
; Amps K; Andrews PW; Anyfantis G; Armstrong L; Avery S; Baharvand H; Baker J; Baker D; Munoz MB; Beil S; Benvenisty N; Ben-Yosef D; Biancotti JC; Bosman A; Brena RM; Brison D; Caisander G; Camarasa MV; Chen J; Chiao E; Choi YM; Choo AB; Collins D; Colman A; Crook JM; Daley GQ; Dalton A; De Sousa PA; Denning C; Downie J; Dvorak P; Montgomery KD; Feki A; Ford A; Fox V; Fraga AM; Frumkin T; Ge L; Gokhale PJ; Golan-Lev T; Gourabi H; Gropp M; Lu G; Hampl A; Harron K; Healy L; Herath W; Holm F; Hovatta O; Hyllner J; Inamdar MS; Irwanto AK; Ishii T; Jaconi M; Jin Y; Kimber S; Kiselev S; Knowles BB; Kopper O; Kukharenko V; Kuliev A; Lagarkova MA; Laird PW; Lako M; Laslett AL; Lavon N; Lee DR; Lee JE; Li C; Lim LS; Ludwig TE; Ma Y; Maltby E; Mateizel I; Mayshar Y; Mileikovsky M; Minger SL; Miyazaki T; Moon SY; Moore H; Mummery C; Nagy A; Nakatsuji N; Narwani K; Oh SK; Oh SK; Olson C; Otonkoski T; Pan F; Park IH; Pells S; Pera MF; Pereira LV; Qi O; Raj GS; Reubinoff B; Robins A; Robson P; Rossant J; Salekdeh GH; Schulz TC; Sermon K; Sheik Mohamed J; Shen H; Sherrer E; Sidhu K; Sivarajah S; Skottman H; Spits C; Stacey GN; Strehl R; Strelchenko N; Suemori H; Sun B; Suuronen R; Takahashi K; Tuuri T; Venu P; Verlinsky Y; Ward-van Oostwaard D; Weisenberger DJ; Wu Y; Yamanaka S; Young L; Zhou Q
Nat Biotechnol; 2011 Nov; 29(12):1132-44. PubMed ID: 22119741
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic stem cells as models for aneuploid chromosomal syndromes.
Biancotti JC; Narwani K; Buehler N; Mandefro B; Golan-Lev T; Yanuka O; Clark A; Hill D; Benvenisty N; Lavon N
Stem Cells; 2010 Sep; 28(9):1530-40. PubMed ID: 20641042
[TBL] [Abstract][Full Text] [Related]
10. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.
Smith LT; Mayerson J; Nowak NJ; Suster D; Mohammed N; Long S; Auer H; Jones S; McKeegan C; Young G; Bos G; Plass C; Morrison C
Genes Chromosomes Cancer; 2006 Oct; 45(10):957-66. PubMed ID: 16847944
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain.
Guo T; Gu C; Li B; Xu C
Aging (Albany NY); 2021 Aug; 13(15):19750-19759. PubMed ID: 34351305
[TBL] [Abstract][Full Text] [Related]
12. BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells.
Loo LSW; Soetedjo AAP; Lau HH; Ng NHJ; Ghosh S; Nguyen L; Krishnan VG; Choi H; Roca X; Hoon S; Teo AKK
Cell Death Dis; 2020 May; 11(5):378. PubMed ID: 32424151
[TBL] [Abstract][Full Text] [Related]
13. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
14. Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.
Zhang H; Xue J; Hessler P; Tahir SK; Chen J; Jin S; Souers AJ; Leverson JD; Lam LT
Mol Cancer; 2015 Jul; 14():126. PubMed ID: 26134786
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival.
Zhang J; Hirst AJ; Duan F; Qiu H; Huang R; Ji Y; Bai L; Zhang F; Robinson D; Jones M; Li L; Wang P; Jiang P; Andrews PW; Barbaric I; Na J
Stem Cell Reports; 2019 Mar; 12(3):557-571. PubMed ID: 30773485
[TBL] [Abstract][Full Text] [Related]
16. Challenges and approaches to the culture of pluripotent human embryonic stem cells.
Skottman H; Narkilahti S; Hovatta O
Regen Med; 2007 May; 2(3):265-73. PubMed ID: 17511563
[TBL] [Abstract][Full Text] [Related]
17. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
18. Activation of apoptotic signalling events in human embryonic stem cells upon Coxsackievirus B3 infection.
Romorini L; Scassa ME; Videla Richardson G; Blüguermann C; Jaquenod de Giusti C; Questa M; Fernandez Espinosa DD; Gómez RM; Sevlever GE; Miriuka SG
Apoptosis; 2012 Feb; 17(2):132-42. PubMed ID: 22012335
[TBL] [Abstract][Full Text] [Related]
19. AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation.
Lee BS; Cha HY; Shin YS; Kim YS; Kim CH
Endocr Relat Cancer; 2013 Jun; 20(3):283-91. PubMed ID: 23429749
[TBL] [Abstract][Full Text] [Related]
20. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL.
Oh KJ; Lee SC; Choi HJ; Oh DY; Kim SC; Min do S; Kim JM; Lee KS; Han JS
J Cell Biochem; 2007 Aug; 101(6):1409-22. PubMed ID: 17541981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
